Caprelsa (vandetanib) - Serious Risk Of Abnormal Heart Rhythm - For Health Professionals

CAPRELSA Recall Summary CAPRELSA (vandetanib), a cancer medication, is being recalled across Canada due to a serious risk of abnormal heart rhythm in patients who take it. This recall affects all patients currently using or prescribed this drug. Healthcare professionals have been notified about this safety concern with the medication.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2012-02-15

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/4a19919a-9f87-4220-af00-0a2c65a7b049